Welcome to Innovatis Clinical Research

We’ll Ensure You Always Get The Best Result.

Pioneering Excellence in Clinical Trials

At Innovatis, we understand the urgency and precision required in clinical research. Our expertise lies in providing end-to-end solutions for clinical trials across all phases (I-IV), with a special focus on Bioavailability/Bioequivalence (BA/BE) studies and clinical trials (CTs). We partner with clients to ensure timely delivery of life-saving therapeutics while maintaining the highest standards of quality and compliance.

Make An Appointment
Learn More

  • Innovatis CRO understands the urgency of our clients face to deliver a solution. Innovatis plays a vital role in helping our clients to get life-saving therapeutics submitted on time and as per budget.

  • The Employees at our organization are trained to provide professional assistance to the investigator ensuring the compliance with FDA, Local regulatory, ICH-GCP, NDCT Rules 2019 guidelines and efficient completion of mandated tasks.

Our Portfolio

  • Site Feasibility & Pl Selection
  • Site Personnel Training for ICH-GCP, PROTOCOL, EDC, IWRS others.
  • Site Coordination & phase I to IV study management
  • Pharmacokinetic study management.
  • Project Management
  • Quality Assurance/Quality Control
  • Documentation with Electronic Data Capture (EDC) expertise
  • Internal Auditing
  • Contract Monitoring
  • BA/BE Study Management
  • Retrospective study Management
Learn More

Innovatis Expert Team

Dr. Ananth Kumar Kammala

Co-Founder & Chief Scientific Officer, Innovatis CRO

Dr. Ananth Kumar Kammala is a visionary scientist and entrepreneur dedicated to advancing clinical research and drug development. As the Co-Founder and Chief Scientific Officer of Innovatis CRO, he brings a wealth of expertise in reproductive pharmacology, translational research, and clinical trial management. With extensive experience in pharmacokinetics, exosomal drug delivery, and microphysiological systems, Dr. Kammala is committed to bridging the gap between cutting-edge scientific discoveries and real-world therapeutic applications. His leadership ensures that Innovatis CRO upholds the highest regulatory standards, accelerates trial timelines, and delivers high-quality research solutions to pharmaceutical, biotechnology, and healthcare partners globally.

Ms. Bhargavi Reddy Ramireddy

Co-Founder & Chief Scientific Officer, Innovatis CRO

Ms. Bhargavi Reddy Ramireddy is a distinguished pharmacologist, entrepreneur, and industry leader with extensive expertise in pharmaceutical market analysis, hospital management, and clinical research operations. As the Co-Founder and Chief Scientific Officer of Innovatis CRO, she plays a pivotal role in driving strategic growth and ensuring the successful execution of clinical trials across multiple therapeutic areas. With a strong background in regulatory compliance, business development, and healthcare innovation, Ms. Ramireddy has established and managed multiple startups, showcasing her entrepreneurial acumen. Her leadership at Innovatis CRO is instrumental in streamlining clinical operations, optimizing market strategies, and fostering collaborations that enhance drug development and patient care.

Dr Suresh Babu. P MD , DM PDF ( EEF )

HOD Neurology with 12 + years of extensive experience.

Clinical operations head & MD
He is credited with numerous publications and has presented several posters at national conferences.
His diverse experience and in depth knowledge establish him as a prominent figure in the field of neurology.
He posses post doctoral fellowship in electroencephalography and epilepsy.

Address

Sia life LLP Raghvendra Colony Kondapur, Hyderabad

Call Us

+91 7337588550

Email Us

bhargavi.ramireddy@innovatis.co.in